FI20002612A0 - Combination therapy for the treatment of disorders in serotonin turnover - Google Patents

Combination therapy for the treatment of disorders in serotonin turnover

Info

Publication number
FI20002612A0
FI20002612A0 FI20002612A FI20002612A FI20002612A0 FI 20002612 A0 FI20002612 A0 FI 20002612A0 FI 20002612 A FI20002612 A FI 20002612A FI 20002612 A FI20002612 A FI 20002612A FI 20002612 A0 FI20002612 A0 FI 20002612A0
Authority
FI
Finland
Prior art keywords
disorders
treatment
combination therapy
serotonin turnover
serotonin
Prior art date
Application number
FI20002612A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Outi Maeki-Ikola
Original Assignee
Orion Yhtymae Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oyj filed Critical Orion Yhtymae Oyj
Priority to FI20002612A priority Critical patent/FI20002612A0/en
Publication of FI20002612A0 publication Critical patent/FI20002612A0/en
Priority to AU2002218335A priority patent/AU2002218335A1/en
Priority to PCT/FI2001/001029 priority patent/WO2002043724A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20002612A 2000-11-28 2000-11-28 Combination therapy for the treatment of disorders in serotonin turnover FI20002612A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI20002612A FI20002612A0 (en) 2000-11-28 2000-11-28 Combination therapy for the treatment of disorders in serotonin turnover
AU2002218335A AU2002218335A1 (en) 2000-11-28 2001-11-27 Combination therapy for treatment of serotonergic disorders
PCT/FI2001/001029 WO2002043724A1 (en) 2000-11-28 2001-11-27 Combination therapy for treatment of serotonergic disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20002612A FI20002612A0 (en) 2000-11-28 2000-11-28 Combination therapy for the treatment of disorders in serotonin turnover

Publications (1)

Publication Number Publication Date
FI20002612A0 true FI20002612A0 (en) 2000-11-28

Family

ID=8559601

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20002612A FI20002612A0 (en) 2000-11-28 2000-11-28 Combination therapy for the treatment of disorders in serotonin turnover

Country Status (3)

Country Link
AU (1) AU2002218335A1 (en)
FI (1) FI20002612A0 (en)
WO (1) WO2002043724A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003274185A1 (en) * 2002-10-23 2004-05-13 Orion Corporation New uses of deramciclane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179164B (en) * 1979-12-14 1982-08-28 Egyt Gyogyszervegyeszeti Gyar Process for producing cycloalkyl-ethers of alkanolamines
HU226061B1 (en) * 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
EP1133986A1 (en) * 2000-03-17 2001-09-19 Orion Corporation Use of deramciclane for the treatment of anxiety and depression

Also Published As

Publication number Publication date
AU2002218335A1 (en) 2002-06-11
WO2002043724A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
NO20005884D0 (en) Combination therapy for the treatment of bipolar disorders
HK1152243A1 (en) Vegf for use in the treatment of central nervous system disorders vegf
PT1147114E (en) NEW ARALQUILAMINS OF UPRISING SPIROFUROPYRIDINES IN THERAPY.
IS6560A (en) Pharmaceutical composition for the treatment of acute, persistent pain and / or nervous system pain and migraine
NO20044054L (en) Administration of agents for the treatment of inflammation
CY2014005I2 (en) TOPICAL GEL DELIVERY SYSTEMS FOR THE THERAPEUTIC TREATMENT OF SKIN DISORDERS
HK1092367A1 (en) Combination therapy for the treatment of ocular neovascular disorders
DE60142473D1 (en) INTRAKORPORAL MEDICAMENTS FOR THE PHOTODYNAMIC TREATMENT OF ILLNESSES
NO20041588L (en) Use of flibanserin in the treatment of sexual disorders
NO20021845L (en) Treatment of sleep disorders using desloratadine
ID30276A (en) METHODS FOR TREATING SEXUAL DISORDERS
DK1702618T3 (en) Use of ET743 in combination therapy with dexamethasone for the treatment of cancer
IS6137A (en) Treatment of mental disorders
ZA200003236B (en) Combination therapy for the treatment of migraine.
EE9900118A (en) Use of H +, K + -ATPase Inhibitors in the Treatment of Nasal Polyps
NO20023448L (en) Drug combination for the treatment of depression and related disorders including mirtazapine
ZA200110436B (en) Therapeutic use of melatonin.
AU2003259246A8 (en) Methods for the use of neurotoxin in the treatment of urologic disorders
NO20023803L (en) Use of mirtazapine for the treatment of sleep disorders
NO20020784D0 (en) Medication for the treatment of fractures
NO20043445L (en) Combination therapy for the treatment of bacterial infections
PT1305307E (en) EFFECTIVE INDOLE DERIVATIVES IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES
EE200100527A (en) Use of Osanetant in the preparation of medicaments useful for the treatment of mood disorders
NO20012612D0 (en) Isonipecotamides for the treatment of integrin-mediated disorders
FI20002612A0 (en) Combination therapy for the treatment of disorders in serotonin turnover